Literature DB >> 18592405

K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma.

Ioannis D Lyronis1, Stavroula Baritaki, Ioannis Bizakis, Elias Krambovitis, Demetrios A Spandidos.   

Abstract

The Ras/Raf/MEK/ERK (MAPK) signal transduction cascade is an important mediator of a number of cellular fates including growth, survival and apoptosis. The aim of this study was to determine the incidence of B-raf, Kirsten-ras (K-ras) and Neuroblastoma-ras (N-ras) gene mutations in esophageal squamous cell carcinoma (ESCC) in the Greek population. DNA was extracted from 30 ESCC and 32 normal esophageal specimens and screened for V600E B-raf, and K-ras/N-ras codon 12 mutations, by PCR-RFLP based analysis. Among the genes tested, only the heterozygous K-ras mutation was detected in 5 out of the 30 ESCC specimens (16%), whereas no mutation was found in the normal esophageal tissue (P < 0.022). The normal samples were screened negative for N-ras and V600E B-raf mutations. The increased risk of esophageal cancer was correlated with tobacco use (OR = 3.5, P < 0.023) and alcohol abuse (OR = 7.22, P < 0.001), accompanied with the high incidence of the k-ras codon 12 mutation (22%, OR = 1.77 and 21%, OR = 1.52), respectively. A similar positive association was seen in human papilloma virus (HPV)-infected patients (OR = 5.66, P < 0.003). Our overall findings demonstrate that the mutational activation of the K-ras gene, HPV infection and tobacco or alcohol abuse, can be considered independently or in combination as high risk factors for ESCC development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592405     DOI: 10.1007/s12253-008-9032-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

1.  Activation of c-K-ras mutations in human gastrointestinal tumors.

Authors:  N Arber; I Shapira; J Ratan; B Stern; H Hibshoosh; M Moshkowitz; M Gammon; I Fabian; Z Halpern
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

Review 2.  Guilty as charged: B-RAF is a human oncogene.

Authors:  Mathew J Garnett; Richard Marais
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

Review 3.  Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

Authors:  C Scully; J K Field; H Tanzawa
Journal:  Oral Oncol       Date:  2000-07       Impact factor: 5.337

Review 4.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

5.  Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

Authors:  Karin Fransén; Maria Klintenäs; Anna Osterström; Jan Dimberg; Hans-Jürg Monstein; Peter Söderkvist
Journal:  Carcinogenesis       Date:  2003-12-19       Impact factor: 4.944

6.  Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.

Authors:  Il-Jin Kim; Jae-Hyun Park; Hio Chung Kang; Yong Shin; Hye-Won Park; Hye-Rin Park; Ja-Lok Ku; Seok-Byung Lim; Jae-Gahb Park
Journal:  Hum Genet       Date:  2003-09-25       Impact factor: 4.132

Review 7.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  BRAF and KRAS mutations in stomach cancer.

Authors:  Sug Hyung Lee; Jong Woo Lee; Young Hwa Soung; Hong Sug Kim; Won Sang Park; Su Young Kim; Jong Heun Lee; Jik Young Park; Yong Gu Cho; Chang Jae Kim; Suk Woo Nam; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer.

Authors:  Alessandra Tavani; Michaela Bertuzzi; Renato Talamini; Silvano Gallus; Maria Parpinel; Silvia Franceschi; Fabio Levi; Carlo La Vecchia
Journal:  Oral Oncol       Date:  2003-10       Impact factor: 5.337

View more
  15 in total

1.  TRAF6 promoted the metastasis of esophageal squamous cell carcinoma.

Authors:  Qingqi Han; Feng Yao; Chenxi Zhong; Heng Zhao
Journal:  Tumour Biol       Date:  2013-09-13

Review 2.  Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.

Authors:  Savas Tsikis; Lea Hoefer; Angella Charnot-Katsikas; John A Schneider
Journal:  Eur J Cancer Prev       Date:  2016-11       Impact factor: 2.497

3.  Human papillomavirus and the risk of Barrett's esophagus.

Authors:  H B El-Serag; J M Hollier; P Gravitt; A Alsarraj; M Younes
Journal:  Dis Esophagus       Date:  2012-08-14       Impact factor: 3.429

4.  Dissecting GI phenotype-genotype relationships in GERD and dyspepsia: an SNP here and an SNP there!

Authors:  Janusz A Jankowski; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-01-20       Impact factor: 10.864

5.  Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models.

Authors:  Xianhua Wu; Jingchuan Zhang; Ruheng Zhen; Jing Lv; Li Zheng; Xinying Su; Guanshan Zhu; Paul R Gavine; Songtao Xu; Shaohua Lu; Jun Hou; Yalan Liu; Chen Xu; Yunshan Tan; Liang Xie; Xiaolu Yin; Deming He; Qunsheng Ji; Yingyong Hou; Di Ge
Journal:  J Transl Med       Date:  2012-08-30       Impact factor: 5.531

6.  Locally advanced cancer of the esophagus, current treatment strategies, and future directions.

Authors:  Osama E Rahma; Tim F Greten; Austin Duffy
Journal:  Front Oncol       Date:  2012-05-24       Impact factor: 6.244

7.  Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma.

Authors:  Xiao Li; Jing Suo; Shujuan Shao; Liyan Xue; Wei Chen; Lijia Dong; Ji Shi; Ming Fu; Ning Lu; Qimin Zhan; Tong Tong
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.

Authors:  Kuan-Der Lee; Chang-Hsien Lu; Ping-Tsung Chen; Chunghuang Hubert Chan; Jen-Tsun Lin; Cih-En Huang; Chih-Cheng Chen; Min-Chi Chen
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

Review 9.  Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

Authors:  H A Hardefeldt; M R Cox; G D Eslick
Journal:  Epidemiol Infect       Date:  2014-06       Impact factor: 4.434

10.  High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.

Authors:  Zhimin Zhang; Hualiang Xiao; Fei Xie; Hui Zhang; Chuan Chen; He Xiao; Zhenzhou Yang; Dong Wang; Zengpeng Li; Ge Wang
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.